FDA Approved: METHAZOLAMIDE — Original Application (Precision Dose, Inc.)

View source ↗

Summary

FDA approved Precision Dose, Inc.'s original application for methazolamide, a carbonic anhydrase inhibitor, as a new generic product for glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Methazolamide (Methazolamide)

Snippet

ORIG AP for METHAZOLAMIDE (METHAZOLAMIDE)